Adma Biologics Inc Insider ownership
What is the Insider ownership of Adma Biologics Inc?
The Insider ownership of Adma Biologics Inc is 2.02%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to Adma Biologics Inc
What does Adma Biologics Inc do?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Companies with insider ownership similar to Adma Biologics Inc
- Huron Consulting Inc has Insider ownership of 2.01%
- Reliance Worldwide has Insider ownership of 2.01%
- Sigma Lithium Resources has Insider ownership of 2.01%
- Aeglea BioTherapeutics Inc has Insider ownership of 2.01%
- Haynes International has Insider ownership of 2.01%
- LogMeIn has Insider ownership of 2.02%
- Adma Biologics Inc has Insider ownership of 2.02%
- Australian Foundation Investment has Insider ownership of 2.02%
- London Stock Exchange plc has Insider ownership of 2.02%
- Dine Brands Global Inc has Insider ownership of 2.02%
- Delta Resources has Insider ownership of 2.02%
- LXP Industrial Trust has Insider ownership of 2.02%
- MasterCraft Boat Inc has Insider ownership of 2.03%